FORMULATION AND IN VITRO CHARACTERISATION OF ATENOLOL TRANSDERMAL FILM WITH NATURAL POLYSACCHARIDE
DOI:
https://doi.org/10.22159/ijap.2025v17i6.53930Keywords:
Transdermal drug delivery systems (TDDS), Chia seed mucilage (CSM), Atenolol, HPMC, Carboxymethylation, Dibutyl phthalate, Drug releaseAbstract
Objective: The objective of this research work targeted to create a mechanism for transdermal drug delivery containing atenolol with natural polysaccharide and modified natural polymeric combinations, using solvent evaporation technique and to analyse how polymers affect the transdermal patches physicochemical and drug-release characteristics.
Methods: Solvent casting method has been used to formulate transdermal film. Chia seed mucilage (CSM), Carboxymethylated chia seed mucilage, Hydroxypropyl methylcellulose (HPMC) and Gelatin in different combination ratios were used as the polymer. Dibutyl phthalate was chosen as a plasticizer.
Results: Result showed that the thickness of all film varied from 0.0546±0.0048 to 0.073±0.0032 mm with uniformity of thickness in each formulation. The average moisture content is found to be ranging between 4.8±0.13 to 5.67±0.14%. All batches had drug contents varying between 96 to 98 percent. All batches showed folding endurance grades exceeding 120. In comparison to formulation samples F1 to F4 (62.39%, 63.03%, 41.90%, and 23.68%, respectively), formulation samples F5 and F6 showed slower cumulative drug release of 35.26% and 34.27% at 480 min.
Conclusion: According to the study’s findings, modifying the polymer has an impact on the transdermal film’s physicochemical and drug-release characteristics, and formulating an efficient transdermal film requires an optimum ratio of polymer to plasticizer combination. Higher proportion of modified polymer and plasticizer in the formulation of transdermal film, gives lower percentage drug release from prepared film. Thus, it can be concluded that the increase in the ratio of plasticizer and modified CSM polymer in comparison to unmodified CSM polymer will result in retarding drug release rate.
References
1. Ramadon D, McCrudden MT, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res. 2022;12(4):758-91. doi: 10.1007/s13346-021-00909-6, PMID 33474709.
2. Kanase VG, Dani SM, Pandagale PM. Salvia hispanica (chia) seeds a review on pharmacological benefits, nutraceutical properties, extraction method and applications. Int J Pharm Sci Res. 2022;13(6):2263-73. doi: 10.13040/IJPSR.0975-8232.13(6).2263-73.
3. Fancher IS, Rubinstein I, Levitan I. Potential strategies to reduce blood pressure in treatment-resistant hypertension using food and drug Administration-approved nanodrug delivery platforms. Hypertension. 2019 Feb;73(2):250-7. doi: 10.1161/HYPERTENSIONAHA.118.12005, PMID 30624988.
4. Li J, Chen B, Yu T, Guo M, Zhao S, Zhang Y. An efficient controlled release strategy for hypertension therapy: folate-mediated lipid nanoparticles for oral peptide delivery. Pharmacol Res. 2020 Jul 1;157:104796. doi: 10.1016/j.phrs.2020.104796, PMID 32278048.
5. Moradifar N, Kiani AA, Veiskaramian A, Karami K. Role of organic and inorganic nanoparticles in the drug delivery system for hypertension treatment: a systematic review. Curr Cardiol Rev. 2022 Jan 1;18(1):e110621194025. doi: 10.2174/1573403X17666210611115823, PMID 35297343.
6. Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chem Rev. 2016 Feb 24;116(4):2602-63. doi: 10.1021/acs.chemrev.5b00346, PMID 26854975.
7. Fard MM, Fard AM. Modeling drug release. Eurasian J Sci Technol. 2022;2(1):14-33.
8. Rastogi V, Upadhyay P. A brief view on antihypertensive drugs delivery through transdermal patches. Int J Pharm Sci Res. 2012:3(7):1955. doi: 10.13040/IJPSR.0975-8232.3(7).1955-70.
9. Marineli RS, Moraes EA, Lenquiste SA, Godoy AT, Eberlin MN, Marostica Jr MR. Chemical characterization and antioxidant potential of Chilean chia seeds and oil (Salvia hispanica L.). LWT Food Sci Technol. 2014 Dec 1;59(2):1304-10. doi: 10.1016/j.lwt.2014.04.014.
10. Munoz LA, Cobos A, Diaz O, Aguilera JM. Chia seeds: microstructure, mucilage extraction and hydration. J Food Eng. 2012 Jan 1;108(1):216-24. doi: 10.1016/j.jfoodeng.2011.06.037.
11. Souza AL, Martinez FP, Ferreira SB, Kaiser CR. A complete evaluation of thermal and oxidative stability of chia oil: the richest natural source of α-linolenic acid. J Therm Anal Calorim. 2017 Dec;130(3):1307-15. doi: 10.1007/s10973-017-6106-x.
12. Korczak R, Kamil A, Fleige L, Donovan SM, Slavin JL. Dietary fiber and digestive health in children. Nutr Rev. 2017 Apr 1;75(4):241-59. doi: 10.1093/nutrit/nuw068, PMID 28586481.
13. Scapin G, Schmidt MM, Prestes RC, Rosa CS. Phenolic compounds, flavonoids and antioxidant activity of chia seed extracts (Salvia hispanica) obtained by different extraction conditions. Int Food Res J. 2016 Dec 22;23(6):2341-6.
14. Cuomo F, Iacovino S, Cinelli G, Messia MC, Marconi E, Lopez F. Effect of additives on chia mucilage suspensions: a rheological approach. Food Hydrocoll. 2020 Dec 1;109:106118. doi: 10.1016/j.foodhyd.2020.106118.
15. Chakka VP, Zhou T. Carboxymethylation of polysaccharides: synthesis and bioactivities. Int J Biol Macromol. 2020 Dec 15;165(B):2425-31. doi: 10.1016/j.ijbiomac.2020.10.178, PMID 33132131.
16. Li Y, Yuan Y, Lei L, Li F, Zhang Y, Chen J. Carboxymethylation of polysaccharide from Morchella angusticepes peck enhances its cholesterol-lowering activity in rats. Carbohydr Polym. 2017 Sep 15;172:85-92. doi: 10.1016/j.carbpol.2017.05.033, PMID 28606551.
17. Parhi R, Padilam S. In vitro permeation and stability studies on developed drug in adhesive transdermal patch of simvastatin. Bull Fac Pharm Cairo Univ. 2018 Jun 1;56(1):26-33. doi: 10.1016/j.bfopcu.2018.04.001.
18. Lu Y, Luo Q, Chu Y, Tao N, Deng S, Wang L. Application of gelatin in food packaging: a review. Polymers. 2022 Jan 21;14(3):436. doi: 10.3390/polym14030436, PMID 35160426.
19. Liu Y, Sun Y, Huang G. Preparation and antioxidant activities of important traditional plant polysaccharides. Int J Biol Macromol. 2018 May 1;111:780-6. doi: 10.1016/j.ijbiomac.2018.01.086, PMID 29355627.
20. Liu X, Wang X, Xu X, Zhang X. Purification antitumor and anti-inflammation activities of an alkali-soluble and carboxymethyl polysaccharide CMP33 from Poria cocos. Int J Biol Macromol. 2019 Apr 15;127:39-47. doi: 10.1016/j.ijbiomac.2019.01.029, PMID 30629996.
21. Ah YC, Choi JK, Choi YK, Ki HM, Bae JH. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int J Pharm. 2010 Jan 29;385(1-2):12-9. doi: 10.1016/j.ijpharm.2009.10.013, PMID 19833177.
22. Bhagyeshwar G, Ramu B, Rajkamal B. Formulation and evaluation of transdermal patches of metformin hydrochloride. World Res J Pharm Technol. 2017;2(4):1-20.
23. Amjad M, Ehtheshamuddin M, Chand S, Hanifa SM, Asia R, Kumar GS. Formulation and evaluation of transdermal patches of atenolol. Adv Res Pharm Biol. 2011 Oct;1(2):12-23.
24. Kulkarni RV, Mutalik S, Hiremath D. Effect of plasticizers on the permeability and mechanical properties of Eudragit films for transdermal application. Indian J Pharm Sci. 2002;64(1):28-31.
25. Budhathoki U, Gartoulla K, Shakya S. Formulation and evaluation of transdermal patches of atenolol. Indonesian J Pharm. 2016 Dec 23;27(4):196. doi: 10.14499/indonesianjpharm27iss4pp196.
26. Sivasankarapillai VS, Das SS, Sabir F, Sundaramahalingam MA, Colmenares JC, Prasannakumar S. Progress in natural polymer engineered biomaterials for transdermal drug delivery systems. Mater Today Chem. 2021 Mar 1;19:100382. doi: 10.1016/j.mtchem.2020.100382.
27. Biswas D, Das S, Mohanto S, Mantry S. Extraction modification and characterization of natural polymers used in transdermal drug delivery system: an updated review. Asian J Pharm Clin Res. 2020;13(7):10-20. doi: 10.22159/ajpcr.2020.v13i7.37756.
28. Mo L, Lu G, Ou X, Ouyang D. Formulation and development of novel controlled-release transdermal patches of carvedilol to improve bioavailability for the treatment of heart failure. Saudi J Biol Sci. 2022 Jan 1;29(1):266-72. doi: 10.1016/j.sjbs.2021.08.088, PMID 35002418.
29. Kandalkar A, Dhole R, Jawarkar S, Patel A, Pawar D, Wagh H. Transdermal telmisartan patch development with natural permeation enhancers: ex vivo release comparison. J Namibian Stud Hist Polit Cult. 2023 Aug 10;35(1):3504-23. doi: 10.59670/jns.v35i.4242.
30. Maruti MM, Shirsat MK. Formulation and characterization of multilayered controlled-release topical patch for cure of cardiac disease. NVEO Nat Volat Essent Oils J. 2021 Dec 20;8(4)13737-64.
31. Hardainiyan SW, Kumar KR, Nandy BC, Saxena RI. Design formulation and in vitro drug release from transdermal patches containing imipramine hydrochloride as model drug. Int J Pharm Pharm Sci. 2017 Jun 1;9(6):220. doi: 10.22159/ijpps.2017v9i6.16851.
32. Gannu R, Vishnu YV, Kishan V, Rao YM. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. Curr Drug Deliv. 2007 Jan 1;4(1):69-76. doi: 10.2174/156720107779314767, PMID 17269919.
33. Hasnain MS, Guru PR, Rishishwar P, Ali S, Ansari MT, Nayak AK. Atenolol-releasing buccal patches made of Dillenia indica L. fruit gum: preparation and ex vivo evaluations. SN Appl Sci. 2020 Jan;2(1). doi: 10.1007/s42452-019-1756-x.
34. Kim HS, Yun YH, Shim WG, Yoon SD. Preparation of atenolol imprinted polysaccharide-based biomaterials for a transdermal drug delivery system. J Drug Deliv Sci Technol. 2020 Oct 1;59:101893. doi: 10.1016/j.jddst.2020.101893.
35. Adhikari SN, Panda S. Development, evaluation and characterization of buccal patches containing atenolol using hydrophilic polymers. Int J Appl Pharm. 2022;14(2):61-7. doi: 10.22159/ijap.2022v14i2.43589.
36. Mehta P, Al Kinani AA, Arshad MS, Chang MW, Alany RG, Ahmad Z. Development and characterisation of electrospun timolol maleate loaded polymeric contact lens coatings containing various permeation enhancers. Int J Pharm. 2017 Oct 30;532(1):408-20. doi: 10.1016/j.ijpharm.2017.09.029, PMID 28917987.
37. Bialik M, Kurkowski P, Strzelecka K, Kuras M, Sobczak M, Mulas K. Dual-controlled delivery of furosemide and atenolol using a biodegradable nanosystem for antihypertensive therapy. J Drug Deliv Sci Technol. 2023 Nov 1;89:105006. doi: 10.1016/j.jddst.2023.105006.
38. Zhang K, Zhuang Y, Li J, Liu X, He S. Poly(acrylic acid) modified MoS2 nanoparticle based transdermal delivery of atenolol. Int J Nanomedicine. 2020 Aug 4;15:5517-26. doi: 10.2147/IJN.S257906, PMID 32801703.
39. Ahad A, Al Jenoobi FI, Al Mohizea AM, Akhtar N, Raish M, Aqil M. Systemic delivery of β-blockers via transdermal route for hypertension. Saudi Pharm J. 2015 Nov 1;23(6):587-602. doi: 10.1016/j.jsps.2013.12.019, PMID 26702253.
40. Noreen S, Ma JX, Saeed M, Pervaiz F, Hanif MF, Ahmed B. Natural polysaccharide-based biodegradable polymeric platforms for transdermal drug delivery system: a critical analysis. Drug Deliv Transl Res. 2022 Nov;12(11):2649-66. doi: 10.1007/s13346-022-01152-3, PMID 35499715.
Published
How to Cite
Issue
Section
Copyright (c) 2025 SWARNIM GUPTA, RIMA DAWN, ABHISHEK JANA, DEBARATI KAR, TATHAGATA ROY, PINTU KUMAR DE
This work is licensed under a Creative Commons Attribution 4.0 International License.
